Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme

  • Authors:
    • Angelantonio Notarangelo
    • Domenico Trombetta
    • Vincenzo D'Angelo
    • Paola Parrella
    • Orazio Palumbo
    • Clelia Tiziana Storlazzi
    • Luciana Impera
    • Lucia Anna Muscarella
    • Antonella La Torre
    • Andrea Affuso
    • Vito Michele Fazio
    • Massimo Carella
    • Leopoldo Zelante
  • View Affiliations

  • Published online on: December 23, 2013     https://doi.org/10.3892/ijo.2013.2224
  • Pages: 717-724
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma multiforme (World Health Organ­ization, grade IV astrocytoma) is the most common and most aggressive malignant primary brain tumor. We report a novel cell line, designated as ANGM-CSS, which was established from a 56-year-old male patient with a surgically removed glioblastoma multiforme. The ANGM-CSS cell line was established in vitro and characterized using histological and immunohistochemical staining, classical and molecular cytogenetic analyses, molecular studies and functional assays using a xenograft model in immunodeficient animals. ANGM-CSS was positive for CD133, nestin and vimentin proteins, whereas GFAP showed staining only in a fraction of the cells. Cytogenetic and molecular cytogenetic analysis revealed a near-tetraploid karyotype, with a modal chromosome number from 88 to 91, and additional cytogenetic abnormalities, such as the t(6;14)(p12;q11.2), t(8;10)(q24.2;q21.1) and t(5;9)(q34;p21) unbalanced translocations. Moreover, ANGM-CSS showed amplification of the MET and EGFR genes whose overexpression was observed at the mRNA level. Interestingly, ANGM-CSS is tumorigenic when implanted in immunodeficient mice, and the cells obtained from the xenografts showed the same morphology and karyotype in vitro as the original cell line. ANGM-CSS represents a biologically relevant cell line to be used to investigate the molecular pathology of glioblastoma multiforme, also to evaluate the efficacy of novel therapeutic drugs in vitro.
View Figures
View References

Related Articles

Journal Cover

2014-March
Volume 44 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Notarangelo A, Trombetta D, D'Angelo V, Parrella P, Palumbo O, Storlazzi CT, Impera L, Muscarella LA, La Torre A, Affuso A, Affuso A, et al: Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme. Int J Oncol 44: 717-724, 2014
APA
Notarangelo, A., Trombetta, D., D'Angelo, V., Parrella, P., Palumbo, O., Storlazzi, C.T. ... Zelante, L. (2014). Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme. International Journal of Oncology, 44, 717-724. https://doi.org/10.3892/ijo.2013.2224
MLA
Notarangelo, A., Trombetta, D., D'Angelo, V., Parrella, P., Palumbo, O., Storlazzi, C. T., Impera, L., Muscarella, L. A., La Torre, A., Affuso, A., Fazio, V. M., Carella, M., Zelante, L."Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme". International Journal of Oncology 44.3 (2014): 717-724.
Chicago
Notarangelo, A., Trombetta, D., D'Angelo, V., Parrella, P., Palumbo, O., Storlazzi, C. T., Impera, L., Muscarella, L. A., La Torre, A., Affuso, A., Fazio, V. M., Carella, M., Zelante, L."Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme". International Journal of Oncology 44, no. 3 (2014): 717-724. https://doi.org/10.3892/ijo.2013.2224